Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Delivery of factor VIII gene using lentiviral vectors reported by Cell Genesys

April 14, 2000

Synthetic factor Xa inhibitor better than LMWH in rat model of DIC

April 7, 2000

Merck describes preparation and use of new anticoagulants

April 5, 2000

Novel anticoagulant presented by Ajinomoto at Japanese Pharmacological Society meeting

April 3, 2000

Novel antiplatelet agents in the Searle pipeline

April 3, 2000

Highly potent and orally bioavailable nonbenzamidine factor Xa inhibitors presented to ACS

March 29, 2000

3-Dimensional Pharmaceuticals begins clinical testing of oral thrombin inhibitor

March 29, 2000

Nonpeptide protease inhibitors designed and evaluated at 3-D

March 28, 2000

CPMP recommends approval of Kogenate Bayer as hemophilia A treatment

March 27, 2000

Orally bioavailable gpIIb/IIIa receptor antagonist ME-3230 profiled at Japanese meeting

March 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...